These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30464637)

  • 1. Oral metronidazole use and risk of acute pancreatitis: a population-based case-control study.
    Barbulescu A; Oskarsson V; Lindblad M; Ljung R; Brooke HL
    Clin Epidemiol; 2018; 10():1573-1581. PubMed ID: 30464637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metronidazole and risk of acute pancreatitis: a population-based case-control study.
    Nørgaard M; Ratanajamit C; Jacobsen J; Skriver MV; Pedersen L; Sørensen HT
    Aliment Pharmacol Ther; 2005 Feb; 21(4):415-20. PubMed ID: 15709992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study.
    Sadr-Azodi O; Mattsson F; Bexlius TS; Lindblad M; Lagergren J; Ljung R
    JAMA Intern Med; 2013 Mar; 173(6):444-9. PubMed ID: 23440105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of acute pancreatitis among tetracycline users in a Swedish population-based case-control study.
    Ljung R; Lagergren J; Bexelius TS; Mattsson F; Lindblad M
    Gut; 2012 Jun; 61(6):873-6. PubMed ID: 21957155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
    Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI
    Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori eradication in the Swedish population.
    Doorakkers E; Lagergren J; Gajulapuri VK; Callens S; Engstrand L; Brusselaers N
    Scand J Gastroenterol; 2017; 52(6-7):678-685. PubMed ID: 28323552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II receptor blockers and risk of acute pancreatitis - a population based case-control study in Sweden.
    Bexelius TS; Ljung R; Mattsson F; Lu Y; Lindblad M
    BMC Gastroenterol; 2017 Mar; 17(1):36. PubMed ID: 28270103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan.
    Sugimoto M; Sahara S; Ichikawa H; Kagami T; Ban H; Otsuka T; Andoh A; Furuta T
    Helicobacter; 2017 Feb; 22(1):. PubMed ID: 27213463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
    Bochenek WJ; Peters S; Fraga PD; Wang W; Mack ME; Osato MS; El-Zimaity HM; Davis KD; Graham DY;
    Helicobacter; 2003 Dec; 8(6):626-42. PubMed ID: 14632678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
    Salmanroghani H; Mirvakili M; Baghbanian M; Salmanroghani R; Sanati G; Yazdian P
    PLoS One; 2018; 13(6):e0197096. PubMed ID: 29889843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy and risk of acute pancreatitis.
    Razavi D; Lindblad M; Bexelius T; Oskarsson V; Sadr-Azodi O; Ljung R
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1337-1341. PubMed ID: 27651204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.
    Fischbach LA; Bravo LE; Zarama GR; Bravo JC; Ojha RP; Priest EL; Collazos T; Casabon AL; Guerrero LZ; Singh KP; Correa P
    Helicobacter; 2009 Apr; 14(2):100-8. PubMed ID: 19298337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan.
    Liao KF; Huang PT; Lin CC; Lin CL; Lai SW
    Biomedicine (Taipei); 2017 Sep; 7(3):17. PubMed ID: 28840831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Peripheral Neuropathy and Exposure to Oral Fluoroquinolone or Amoxicillin-Clavulanate Therapy.
    Morales D; Pacurariu A; Slattery J; Pinheiro L; McGettigan P; Kurz X
    JAMA Neurol; 2019 Jul; 76(7):827-833. PubMed ID: 31034074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Three 7-Day Pantoprazole-Based Helicobacter pylori Eradication Regimens in a Mexican Population with High Metronidazole Resistance.
    Dehesa M; Larisch J; Dibildox M; Di Silvio M; Lopez LH; Ramirez-Barba E; Torres J
    Clin Drug Investig; 2002; 22(2):75-85. PubMed ID: 23315395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.
    Azoulay L; Filion KB; Platt RW; Dahl M; Dormuth CR; Clemens KK; Durand M; Hu N; Juurlink DN; Paterson JM; Targownik LE; Turin TC; Ernst P; ; Suissa S; Dormuth CR; Hemmelgarn BR; Teare GF; Caetano P; Chateau D; Henry DA; Paterson JM; LeLorier J; Levy AR; Ernst P; Platt RW; Sketris IS
    JAMA Intern Med; 2016 Oct; 176(10):1464-1473. PubMed ID: 27479930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infection.
    Puig I; González-Santiago JM; Molina-Infante J; Barrio J; Herranz MT; Algaba A; Castro M; Gisbert JP; Calvet X
    Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28869699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.
    Greenberg ER; Anderson GL; Morgan DR; Torres J; Chey WD; Bravo LE; Dominguez RL; Ferreccio C; Herrero R; Lazcano-Ponce EC; Meza-Montenegro MM; Peña R; Peña EM; Salazar-Martínez E; Correa P; Martínez ME; Valdivieso M; Goodman GE; Crowley JJ; Baker LH
    Lancet; 2011 Aug; 378(9790):507-14. PubMed ID: 21777974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
    Sancar M; Izzettin FV; Apikoglu-Rabus S; Besisik F; Tozun N; Dulger G
    Pharm World Sci; 2006 Aug; 28(4):207-14. PubMed ID: 17066247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication.
    Chuah SK; Liang CM; Lee CH; Chiou SS; Chiu YC; Hu ML; Wu KL; Lu LS; Chou YP; Chang KC; Kuo CH; Kuo CM; Hu TH; Tai WC
    Medicine (Baltimore); 2016 May; 95(19):e3586. PubMed ID: 27175657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.